NDC 17856-1122-01 - MAX relief junior Grape
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-1122
- Requested NDC
- 17856-1122-01
- Package NDCs from labels
- 17856-1122-5, 17856-1122-1, 17856-1122-8, 17856-1122-4, 17856-1122-6, 17856-1122-2, 17856-1122-7, 17856-1122-3, 17856-1122-9, 17856-1122-01
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2026-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MAX relief junior Grape - ATLANTIC BIOLOGICALS CORP. | ATLANTIC BIOLOGICALS CORP. | 2026-02-13 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-1122-1 | MAX relief junior Grape | 50 in 1 BOX, UNIT-DOSE | LIQUID | 50 | 4 | |
| 17856-1122-2 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-3 | MAX relief junior Grape | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 4 | |
| 17856-1122-4 | MAX relief junior Grape | 72 in 1 BOX, UNIT-DOSE | LIQUID | 72 | 4 | |
| 17856-1122-5 | MAX relief junior Grape | 20.3 mL in 1 CUP, UNIT-DOSE | LIQUID | 20.3 | 4 | |
| 17856-1122-6 | MAX relief junior Grape | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 4 | |
| 17856-1122-7 | MAX relief junior Grape | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 4 | |
| 17856-1122-8 | MAX relief junior Grape | 15 mL in 1 CUP, UNIT-DOSE | LIQUID | 15 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 60 in 1 BOX, UNIT-DOSE | LIQUID | 60 | 4 | |
| 17856-1122-9 | MAX relief junior Grape | 1 mL in 1 SYRINGE | LIQUID | 1 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-1122 | MAX RELIEF JUNIOR GRAPE (CHILDRENS ACETAMINOPHEN) LIQUID [ATLANTIC BIOLOGICALS CORP.] | 3 | Current NDC, 10 package rows | 20250514_562d7901-44d6-4d9b-be8b-a8d468a22c43.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-1122-1 | ML - Milliliter | 17856-1122 | 6ff0a9b2-03be-4ea1-8611-39fbd5be4f4b | 1 | 2026-02-05 |
| 17856-1122-5 | ML - Milliliter | 17856-1122 | 8df3891c-73a2-47c4-bcee-72eea1317e38 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Sandoz Inc | 3b4ab1cf-8642-44f5-b3a2-3f1f7c620ce9 | 2020-05-14 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Butalbital and Acetaminophen | BUTALBITAL AND ACETAMINOPHEN TABLETS | Oceanside Pharmaceuticals | d2213ffd-18f6-45f5-9af7-690a977562c4 | 2020-04-02 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN 500 MG | Allegiant Health | 8e60b78e-ef3c-4d44-b8d4-37cb8608a5c7 | 2020-03-13 | Warnings | M013 362O9ITL9D |
| Sorbitol | SORBITOL | Baxter Healthcare Corporation | aea0b5a1-444b-4330-a3ce-26485dbbfe75 | 2019-12-31 | Warnings, Adverse reactions | 506T60A25R |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | XLCare Pharmaceuticals, Inc. | 73dea6de-20cb-4cef-b987-3ab2c64e5edb | 2019-11-21 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL | |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | dd4dbe5b-8d07-4a96-a78d-2f20da761dad | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | 6253b3ae-bb52-4532-8d1f-756c0b1577c7 | 2019-11-01 | Warnings, Adverse reactions | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | 0233de1c-466b-4842-8604-6d879aa36a4b | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Oxycodone and Acetaminophen | OXYCODONE AND ACETAMINOPHEN | Proficient Rx LP | df97ea5a-51df-453b-b1b4-edc74c718ee7 | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| butalbital, acetaminophen and caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Lannett Company, Inc. | c1107153-494b-4068-8500-96bc241187a5 | 2019-06-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Butalbital, Acetaminophen, Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Westminster Pharmaceuticals, LLC | 1c0511d0-fe63-45c6-8da2-6ceeb56edb17 | 2019-03-01 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Aphena Pharma Solutions - Tennessee, LLC | 89134c3e-ec5b-4a57-952a-98d6c6cff7c2 | 2019-02-26 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.